Medscape InDiscussion: Idiopathic Pulmonary Fibrosis

Medscape
  • 5.0 (9)
  • SCIENCE
  • SERIES

Listen to Medscape InDiscussion: Idiopathic Pulmonary Fibrosis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982421). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

See All

  1. EPISODE 1

    Considerations Around Supplemental Oxygen for Patients With IPF

    Dr Jeffrey Swigris and Susan Jacobs discuss considerations around supplemental oxygen for patients with idiopathic pulmonary fibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999858. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Idiopathic Pulmonary Fibrosis (IPF) https://emedicine.medscape.com/article/301226-overview Summary for Clinicians: Clinical Practice Guideline on Home Oxygen Therapy for Adults With Chronic Lung Disease https://pubmed.ncbi.nlm.nih.gov/33857391/ Interstitial Lung Disease: Pathophysiology and Genetic Predisposition https://www.medscape.com/viewarticle/408750 The Role of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: An Overview of Systematic Reviews https://pubmed.ncbi.nlm.nih.gov/38127914/

    27 min

  2. EPISODE 2

    How to Integrate Palliative Care into IPF Treatment Plans

    Drs Jeffrey Swigris and Anna Gersten discuss the importance of discussing palliative care with patients and integrating it into IPF treatment plans. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999859. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Idiopathic Pulmonary Fibrosis (IPF) https://emedicine.medscape.com/article/301226-overview Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease https://pubmed.ncbi.nlm.nih.gov/35305969/ Interstitial Lung Disease https://www.medscape.com/viewarticle/408750 The Role of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: An Overview of Systematic Reviews https://pubmed.ncbi.nlm.nih.gov/38127914/ Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis: Time to Treat https://pubmed.ncbi.nlm.nih.gov/31492155/

    29 min

  3. EPISODE 3

    Understanding the Role of Circadian Rhythms in Idiopathic Pulmonary Fibrosis

    Dr Jeffrey Swigris and Isaac Kirubakaran Sundar discuss the complex role of circadian rhythms in patients with idiopathic pulmonary fibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999860. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Idiopathic Pulmonary Fibrosis (IPF) https://emedicine.medscape.com/article/301226-overview Circadian Clock-Based Therapeutics in Chronic Pulmonary Diseases https://pubmed.ncbi.nlm.nih.gov/36302705/ Interstitial Lung Disease: Pathophysiology and Genetic Predisposition https://www.medscape.com/viewarticle/408750 Circadian Timing in the Lung; A Specific Role for Bronchiolar Epithelial Cells https://pubmed.ncbi.nlm.nih.gov/18787022/ The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung https://pubmed.ncbi.nlm.nih.gov/33806395/ TGF-β Signaling in Lung Health and Disease https://pubmed.ncbi.nlm.nih.gov/30127261/

    25 min

  4. EPISODE 4

    Pulmonary Fibrosis Foundation: How Patient Advocacy Is Transforming IPF Research and Care

    Dr Jeffrey Swigris and Scott Staszak discuss how patient advocacy at the Pulmonary Fibrosis Foundation is transforming IPF care and research. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999861. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Pulmonary Fibrosis Foundation https://www.pulmonaryfibrosis.org/ Managing Cough in Idiopathic Pulmonary Fibrosis https://pubmed.ncbi.nlm.nih.gov/34171385/ PFF Help Center https://www.pulmonaryfibrosis.org/patients-caregivers/medical-and-support-resources/pff-help-center PFF Scholars https://www.pulmonaryfibrosis.org/researchers-healthcare-providers/research-opportunities/scholars PFF Registry https://www.pulmonaryfibrosis.org/pff-registry/pff-patient-registry The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and Methods https://pubmed.ncbi.nlm.nih.gov/32776789/ Circulating Biomarker Analyses in a Longitudinal Cohort of Patients With IPF https://pubmed.ncbi.nlm.nih.gov/38226605/ PFF Community Registry https://www.pulmonaryfibrosis.org/pff-registry/community Supplemental Oxygen Access Reform https://www.congress.gov/bill/118th-congress/senate-bill/3821 NHLBI Idiopathic Pulmonary Fibrosis Research https://www.nhlbi.nih.gov/research/idiopathic-pulmonary-fibrosis Department of Defense Basic Research Directorate https://basicresearch.defense.gov/ PFF Become an Advocate https://www.pulmonaryfibrosis.org/advocacy

    27 min

  5. EPISODE 5

    Managing Complex Patients With Pulmonary Hypertension and ILD

    Drs Jeffrey Swigris and M. Patricia George discuss the complexities of diagnosing and treating pulmonary hypertension in patients with interstitial lung disease. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999862. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Idiopathic Pulmonary Fibrosis (IPF) https://emedicine.medscape.com/article/301226-overview Pulmonary Hypertension in Interstitial Lung Disease: An Area of Unmet Clinical Need https://pubmed.ncbi.nlm.nih.gov/36382238/ Assessing the Accuracy of the Lung Allocation Score https://pubmed.ncbi.nlm.nih.gov/34802876/ The 6-Minute Walk Test: Indications and Guidelines for Use in Outpatient Practices https://pubmed.ncbi.nlm.nih.gov/35578650/ Pulmonary Rehabilitation https://emedicine.medscape.com/article/319885-overview Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease https://pubmed.ncbi.nlm.nih.gov/33440084/ Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease https://pubmed.ncbi.nlm.nih.gov/35305969/ PDE5 to Keep Them Alive: The Use of Phosphodiesterase Type-5 Inhibitors in Severe Pulmonary Hypertension Associated With Interstitial Lung Disease https://pubmed.ncbi.nlm.nih.gov/36318987/ Pulmonary Arterial Hypertension https://emedicine.medscape.com/article/303098-overview A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis https://pubmed.ncbi.nlm.nih.gov/20484178/ Diffusing Capacity of the Lungs for Carbon Monoxide https://pubmed.ncbi.nlm.nih.gov/32310609/ Exercise-Induced Pulmonary Hypertension: A Valid Entity or Another Factor of Confusion? https://pubmed.ncbi.nlm.nih.gov/36676077/ Echocardiogram https://www.ncbi.nlm.nih.gov/books/NBK558940/

    31 min

  6. EPISODE 6

    Genetics of Pulmonary Fibrosis: What Is Known and What's to Come?

    Dr Jeffrey Swigris and Janet Talbert discuss the current understanding of the genetics of pulmonary fibrosis, explore the identified genetic pathways, and discuss future research directions. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999863. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Pulmonary Fibrosis Predisposition Overview https://pubmed.ncbi.nlm.nih.gov/20301408/ Aging and Pulmonary Fibrosis https://pubmed.ncbi.nlm.nih.gov/27103043/ Telomere Length and Risk of Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease: A Mendelian Randomisation Study https://pubmed.ncbi.nlm.nih.gov/33197388/ Lung Fibrosis, Premature Graying, and Macrocytosis https://pubmed.ncbi.nlm.nih.gov/22942352/ Idiopathic Pulmonary Fibrosis Is Associated With Common Genetic Variants and Limited Rare Variants https://pubmed.ncbi.nlm.nih.gov/36602845/ Idiopathic Pulmonary Fibrosis and the Role of Genetics in the Era of Precision Medicine https://pubmed.ncbi.nlm.nih.gov/37181377/ Telomeres in Interstitial Lung Disease: The Short and the Long of It https://pubmed.ncbi.nlm.nih.gov/30540921/ Perceptions of Genetic Testing: A Mixed-Methods Study of Patients With Pulmonary Fibrosis and Their First-Degree Relatives https://pubmed.ncbi.nlm.nih.gov/35584322/ American College of Medical Genetics and Genomics https://www.acmg.net/ National Society of Genetic Counselors https://www.nsgc.org/ American Board of Genetic Counselors https://www.abgc.net/

    29 min
See All Season 2 (6)

Ratings & Reviews

5
out of 5
9 Ratings

About

Listen to Medscape InDiscussion: Idiopathic Pulmonary Fibrosis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982421). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Information